Condensed Consolidated Statements of Earnings (unaudited) - USD ($) shares in Millions, $ in Millions |
3 Months Ended | 6 Months Ended | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
Jun. 30, 2024 |
Jun. 30, 2023 |
Jun. 30, 2024 |
Jun. 30, 2023 |
|||||||
| Income Statement [Abstract] | ||||||||||
| Net Sales | $ 1,942.0 | $ 1,869.6 | $ 3,831.2 | $ 3,700.6 | | |||||
| Type of Revenue [Extensible List] | us-gaap:ProductMember | us-gaap:ProductMember | us-gaap:ProductMember | us-gaap:ProductMember | | |||||
| Cost of products sold, excluding intangible asset amortization | $ 553.6 | $ 525.5 | $ 1,065.9 | $ 1,026.3 | | |||||
| Type of Cost, Good or Service [Extensible List] | us-gaap:ProductMember | us-gaap:ProductMember | us-gaap:ProductMember | us-gaap:ProductMember | | |||||
| Intangible asset amortization | $ 144.0 | $ 138.2 | $ 286.1 | $ 271.6 | | |||||
| Research and development | 109.4 | 118.1 | 217.4 | 228.5 | | |||||
| Selling, general and administrative | 737.1 | 725.8 | 1,473.2 | 1,441.8 | | |||||
| Restructuring and other cost reduction initiatives | 41.5 | 24.4 | 165.9 | 66.3 | | |||||
| Acquisition, integration, divestiture and related | 5.2 | 7.9 | 5.5 | 9.1 | | |||||
| Operating expenses | 1,590.8 | 1,539.9 | 3,214.0 | 3,043.6 | | | ||||
| Total Operating Expenses | 3181.6 | 3079.8 | 6428.0 | 6087.2 | 0 | |
||||
| Operating Profit | 351.3 | 329.6 | 617.2 | 656.9 | | |||||
| Other income (expense), net | 2.0 | (1.2) | 1.9 | 6.5 | | | | | | |
| Total Other Income Expenses | 49.1 | 52.8 | 99.9 | 93.3 | 0.0 | |
||||
| Total Other Income Expenses | -51.1 | -54.0 | -101.8 | -99.8 | 0.0 | |
| | ||
| Total Other Income Expenses | -53.1 | -55.2 | -103.7 | -106.3 | 0.0 | |
| | ||
| Total Other Income Expenses | 51.1 | 54.0 | 101.8 | 99.8 | 0.0 | |
| | ||
| Total Other Income Expenses | -49.1 | -52.8 | -99.9 | -93.3 | 0.0 | |
| | ||
| Interest expense, net | (51.1) | (51.6) | (101.8) | (99.8) | | | ||||
| Earnings before income taxes | 302.2 | 276.8 | 517.3 | 563.6 | | |||||
| Provision for income taxes | 59.1 | 66.9 | 101.4 | 121.0 | | |||||
| Net Earnings | 243.1 | 209.9 | 415.9 | 442.6 | | |||||
| Less: Net earnings attributable to noncontrolling interest | 0.3 | 0.2 | 0.7 | 0.5 | ||||||
| Net Earnings of Zimmer Biomet Holdings, Inc. | $ 242.8 | $ 209.6 | $ 415.2 | $ 442.1 | ||||||
| Earnings Per Common Share | ||||||||||
| Basic | $ 1.18 | $ 1 | $ 2.02 | $ 2.12 | ||||||
| Diluted | $ 1.18 | $ 1 | $ 2.01 | $ 2.1 | ||||||
| Weighted Average Common Shares Outstanding | ||||||||||
| Basic | 205.7 | 208.6 | 205.4 | 209.0 | ||||||
| Diluted | 206.4 | 209.9 | 206.3 | 210.1 | ||||||
| X | ||||||||||
- Definition The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Total costs of sales and operating expenses for the period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount after tax of income (loss) from continuing operations attributable to the noncontrolling interest. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount after tax of income (loss) from continuing operations including portion attributable to the noncontrolling interest. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of interest income (expense) classified as operating. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The net result for the period of deducting operating expenses from operating revenues. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of income (expense) related to nonoperating activities, classified as other. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of expense for research and development. Excludes cost for computer software product to be sold, leased, or otherwise marketed, writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both, and write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Indicates type of cost from product sold and service rendered. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Indicates type of revenue from product and service. Includes, but is not limited to, revenue from contract with customer and other sources. No definition available.
|
| X | ||||||||||
- Definition The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Acquisition integration divestiture and related expenses No definition available.
|
| X | ||||||||||
- Definition Restructuring and other cost reduction initiatives . No definition available.
|